GlobalData’s clinical trial report, “Histoplasmosis Global Clinical Trials Review, H2, 2014” provides data on the Histoplasmosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Histoplasmosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Histoplasmosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Histoplasmosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in North America 9
Clinical Trials by G7 Countries: Proportion of Histoplasmosis to Infectious Disease Clinical Trials 10
Clinical Trials in G7 Countries by Trial Status 11
Clinical Trials by Phase 12
In Progress Trials by Phase 13
Clinical Trials by Trial Status 14
Clinical Trials by End Point Status 15
Subjects Recruited Over a Period of Time 16
Clinical Trials by Sponsor Type 17
Prominent Sponsors 18
Top Companies Participating in Histoplasmosis Therapeutics Clinical Trials 19
Prominent Drugs 20
Clinical Trial Profiles 21
Clinical Trial Overview of Top Companies 21
Novartis AG 21
Clinical Trial Overview of Novartis AG 21
Johnson & Johnson 22
Clinical Trial Overview of Johnson & Johnson 22
Janssen Pharmaceuticals, Inc. 23
Clinical Trial Overview of Janssen Pharmaceuticals, Inc. 23
Chemo Espana, S.A. 24
Clinical Trial Overview of Chemo Espana, S.A. 24
Clinical Trial Overview of Top Institutes / Government 25
The National Institute of Allergy and Infectious Diseases 25
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 25
National Eye Institute 26
Clinical Trial Overview of National Eye Institute 26
National Center for Research Resources 27
Clinical Trial Overview of National Center for Research Resources 27
Retina Research Institute of Texas, LLC 28
Clinical Trial Overview of Retina Research Institute of Texas, LLC 28
Retina Associates of Kentucky 29
Clinical Trial Overview of Retina Associates of Kentucky 29
Barnes Retina Institute 30
Clinical Trial Overview of Barnes Retina Institute 30
Five Key Clinical Profiles 31
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 54

List of Tables

Histoplasmosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Histoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Histoplasmosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 9
Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 10
Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 11
Histoplasmosis Therapeutics, Global, Clinical Trials by Phase, 2014* 12
Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 13
Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
Histoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
Histoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 16
Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 17
Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18
Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19
Histoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 20
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 21
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 22
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014* 23
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2014* 24
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 25
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 26
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 27
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Research Institute of Texas, LLC, 2014* 28
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Associates of Kentucky, 2014* 29
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2014* 30

List of Figures

Histoplasmosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 10
Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 11
Histoplasmosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 12
Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 13
Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
Histoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
Histoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 16
Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 17
Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18
Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19
GlobalData Methodology 53